Diadem Biotherapeutics
Tuning immunity
- Headquarters
- Torrance, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- diadembio.com
- Total Funding
- $250K
- Last Round
- $250K SeedNov 2019
About
Diadem Biotherapeutics is a clinical-stage biotechnology company engineering first-in-class extracellular vesicles to treat cancer and autoimmune conditions. Its proprietary DECOSTAR™ platform uses decorated extracellular vesicles for costimulatory activation or repression of immune receptors, solving the biophysical challenges in agonist signaling and enabling access to validated immunotherapy targets. The company is focused on harnessing the untapped potential of immune cell receptor activation to develop novel biologics for chronic inflammatory diseases and oncology.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account